Off-campus UMass Amherst users: To download campus access dissertations, please use the following link to log into our proxy server with your UMass Amherst user name and password.

Non-UMass Amherst users: Please talk to your librarian about requesting this dissertation through interlibrary loan.

Dissertations that have an embargo placed on them will not be available to anyone until the embargo expires.

ORCID

https://orcid.org/0000-0001-7469-2765

Access Type

Campus-Only Access for One (1) Year

Document Type

thesis

Degree Program

Food Science

Degree Type

Master of Science (M.S.)

Year Degree Awarded

2020

Month Degree Awarded

September

Abstract

Bifidobacteria are the predominant members of the infant gut, colonize adults to a lesser extent, and are recognized as beneficial microbes. Various bifidobacterial species produce ��-aminobutryic acid (GABA), the chief inhibitory neurotransmitter in the mammalian central nervous system. It is postulated that in order to produce GABA, the bifidobacterial genome must contain the gadB and gadC genes which encode a glutamate decarboxylase and a glutamate/GABA antiporter, respectively. Once exported by GadC, GABA is absorbed and transported systemically throughout the host. We hypothesize that specific dietary oligosaccharides will modulate bifidobacterial production of GABA due to varying intracellular concentrations of glutamate. To test this, 33 bifidobacterial strains were screened for GABA production via reverse phase HPLC. Interestingly, 10 strains contained both gadB and gadC genes, but only 8 strains produced detectable GABA in vitro. To further elucidate the extrinsic factors influencing GABA production, strains were subjected to different dietary components. Specifically, lactose and the dietary oligosaccharide FOS were evaluated for the ability to promote biosynthesis of intracellular glutamate and thus potentially GABA. Understanding the relationship between diet, bifidobacterial physiology, and GABA production may inform dietary interventions to modulate this neurotransmitter in vivo.

DOI

https://doi.org/10.7275/18054650

First Advisor

David A. Sela

Second Advisor

Amanda J. Kinchla

Third Advisor

Matthew D. Moore

Share

COinS